王佩国, 王世江, 王平. 前列腺癌IMRT的质量保证现状及进展[J]. 中国肿瘤临床, 2008, 35(22): 1310-1313.
引用本文: 王佩国, 王世江, 王平. 前列腺癌IMRT的质量保证现状及进展[J]. 中国肿瘤临床, 2008, 35(22): 1310-1313.
WANG Pei-guo, WANG Shi-jiang, . Intensity Modulated Radiotherapy for Prostate Cancer and Recent Progress[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(22): 1310-1313.
Citation: WANG Pei-guo, WANG Shi-jiang, . Intensity Modulated Radiotherapy for Prostate Cancer and Recent Progress[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(22): 1310-1313.

前列腺癌IMRT的质量保证现状及进展

Intensity Modulated Radiotherapy for Prostate Cancer and Recent Progress

  • 摘要: 适形调强放射治疗(IMRT)是"精确定位、精确计划、精确治疗"的体现,要求在整个治疗过程做到严格的质量保证,对患者选择、定位和治疗的摆位、照射剂量的验证均提出了更高的要求,包括电子射野影像系统、兆伏级锥形束CT、超声等仪器在质量保证过程中的准确应用,并对相对剂量和绝对剂量验证中各种方法有严格的选择。

     

    Abstract: Intensity modulated radiotherapy (IMRT) represents the idea of precise fixing, plan and treatment. IMRT has strict requirements during the treatment such as patient selection, positioning, and dosimetric verificationof irradiation dose. Correct application of electronic portal imaging device system (EPIDs), megavoltagecone-beam CT (MV CBCT) and ultrasound in the quality assurance is very important.

     

/

返回文章
返回